Predominant ligament-centric soft-tissue involvement differentiates axial psoriatic arthritis from ankylosing spondylitis

D McGonagle, P David, T Macleod… - Nature Reviews …, 2023 - nature.com
Since the original description of spondyloarthritis 50 years ago, results have demonstrated
similarities and differences between ankylosing spondylitis (AS) and axial psoriatic arthritis …

The role of IL‐23 and the use of IL‐23 inhibitors in psoriatic arthritis

GE Fragoulis, S Siebert - Musculoskeletal Care, 2022 - Wiley Online Library
Abstract Background Psoriatic arthritis (PsA) is a chronic inflammatory arthritis characterised
by musculoskeletal and extra‐articular manifestations, most notably psoriasis. While the …

Rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis epidemiology in England from 2004 to 2020: an observational study using primary care electronic …

IC Scott, R Whittle, J Bailey, H Twohig… - The Lancet Regional …, 2022 - thelancet.com
Background Contemporary data on rheumatoid arthritis (RA), psoriatic arthritis (PsA) and
axial spondyloarthritis (SpA) epidemiology in England are lacking. This knowledge is crucial …

Efficacy and safety of guselkumab in biologic-naïve patients with active axial psoriatic arthritis: study protocol for STAR, a phase 4, randomized, double-blinded …

DD Gladman, PJ Mease, P Bird, ER Soriano… - Trials, 2022 - Springer
Background Axial involvement constitutes a specific domain of psoriatic arthritis (PsA).
Interleukin (IL)-23 inhibitors have demonstrated improvement in axial PsA (axPsA) …

Efficacy of guselkumab on axial-related symptoms through up to 2 years in adults with active psoriatic arthritis in the phase 3, randomized, placebo-controlled …

PJ Mease, DD Gladman, D Poddubnyy… - Rheumatology and …, 2023 - Springer
Introduction Guselkumab previously showed greater improvements versus placebo in axial
symptoms in patients with psoriatic arthritis (PsA)(assessed by Bath Ankylosing Spondylitis …

Comparison of patients with axial PsA and patients with axSpA and concomitant psoriasis: an analysis of the German register RABBIT-SpA

AC Regierer, A Weiß, F Proft, X Baraliakos… - RMD open, 2023 - rmdopen.bmj.com
Background Psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA) show certain
overlaps: A subset of patients with PsA can develop axial involvement (axial PsA, axPsA) …

Same, same or different? Commonalities and differences between spondyloarthritis and its subsets of axial and peripheral spondyloarthritis with psoriatic arthritis and …

F Proft, H Käding - RMD open, 2023 - rmdopen.bmj.com
Medicine is constantly changing and evolving, and rheumatology in particular is a specialty
in which diseases that were unknown a few decades ago can now be correctly identified …

Managing psoriatic arthritis patients presenting with axial symptoms

D Poddubnyy - Drugs, 2023 - Springer
Axial symptoms (ie, back pain) are common in the general population. At the same time 25–
70% of patients with psoriatic arthritis (PsA) exhibit signs of inflammatory axial involvement …

Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2022

KL Winthrop, JD Isaacs, PJ Mease… - Annals of the …, 2023 - ard.bmj.com
To detail the unmet clinical and scientific needs in the field of rheumatology. After a 2-year
hiatus due to the SARS-CoV-2 pandemic, the 22nd annual international Advances in …

Isolated axial disease in psoriatic arthritis and ankylosing spondylitis with psoriasis

TSH Kwok, M Sutton, D Pereira, RJ Cook… - Annals of the …, 2022 - ard.bmj.com
Objectives To compare isolated axial psoriatic arthritis (PsA), axial PsA with peripheral
involvement and isolated axial ankylosing spondylitis (AS) with psoriasis. To evaluate …